Nh Oncology Hematology, Pa

Hooksett, New Hampshire 03106

0 studies enrolling now · 8 studies all time

What they study most

Androgen-independent Prostate Cancer, Colonic Neoplasms, Colorectal Cancer, Colorectal Neoplasms, Lymphoma, Non-Hodgkin, Metastatic Breast Cancer, Metastatic Prostate Cancer, Non Small Cell Lung Cancer, Non-small Cell Lung Cancer, Rectal Neoplasms

Studies at this site

• PhII ICb With/Without Erbitux in MBC Pts — Running, not enrolling
• Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed
• A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer — Completed
• Phase II Sunitinib Prog Met AIPC — Completed
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) — Completed
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed
• Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer — Completed